Michel Coleman
LONDON—Inequalities in cancer care delivery and overall spending have had a big impact on cancer survival rates in Europe, according to Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene and Tropical Medicine. He gives Peter Goodwin his analysis of data emerging from the Eurocare 4 study in 23 different countries, recently published in the European Journal of Cancer.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.